With only 25% of U.S. practices currently DSO-affiliated, the runway for consolidation remains long, but the tactics for building value are changing fast. Here’s a sneak peek of some of what we cover in this guide:
- The consolidation outlook: Where the remaining 75% of unconsolidated U.S. practices fit into future M&A strategy.
- Same-store growth levers: How tech-assisted workflows and lab consolidation eliminate chair-time loss and boost location-level efficiency.
- Downstream standardisation pressures: Why aligning clinical vendors and technology across your network protects long-term margins.
- Valuation signals for acquirers: How proving operational control and technical consistency increases EBITDA multiples.